Eva M Marco Selected Research

Eva M Marco Research Topics

4	Body Weight (Weight, Body) 01/2017 - 11/2003
3	Ocular Hypertension (Glaucoma, Suspect) 03/2024 - 02/2021
3	Glaucoma 03/2024 - 02/2021
2	Inflammation (Inflammations) 03/2024 - 10/2021
2	Neuroinflammatory Diseases 02/2021 - 01/2021
2	Anhedonia 01/2017 - 05/2014
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2011 - 08/2011
1	Alcoholism (Alcohol Abuse) 01/2022
1	Thiamine Deficiency 01/2022
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 01/2022
1	Korsakoff Syndrome (Wernicke-Korsakoff Syndrome) 01/2021
1	Binge Drinking 01/2017
1	Anxiety Disorders (Anxiety Disorder) 01/2015
1	Pain (Aches) 10/2013
1	Peripheral Nerve Injuries 10/2013
1	Mood Disorders (Mood Disorder) 10/2013
1	AIDS-Related Complex (ARC) 01/2013
1	Weight Gain 09/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2012
1	Feeding and Eating Disorders (Eating Disorder) 09/2012
1	Cachexia 09/2012
1	Mental Disorders (Mental Disorder) 03/2012
1	Marijuana Abuse (Cannabis Abuse) 04/2009

3	CytokinesIBA 10/2021 - 10/2013
2	ChemokinesIBA 10/2021 - 02/2021
2	Retinaldehyde (Retinal)IBA 10/2021 - 02/2021
2	Chemokine CX3CL1IBA 10/2021 - 02/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 02/2021
2	CannabinoidsIBA 09/2012 - 04/2009
1	Cilastatin FDA Link 03/2024
1	Fenofibrate (CiL)FDA LinkGeneric 03/2024
1	Thiamine (Aneurin)FDA Link 01/2022
1	crocinIBA 10/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2021
1	oleoylethanolamideIBA 01/2021
1	Sucrose (Saccharose)IBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 01/2017
1	EnzymesIBA 01/2015
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2015
1	1-biphenyl-4-ylethenyl piperidine-1-carboxylateIBA 01/2015
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2015
1	CorticosteroneIBA 05/2014
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 05/2014
1	Dronabinol (THC)FDA LinkGeneric 01/2013
1	EndocannabinoidsIBA 09/2012
1	Cannabinoid Receptor AgonistsIBA 09/2012
1	24,25-oxidolanosterol (OLAN)IBA 03/2012
1	Triglycerides (Triacylglycerol)IBA 03/2012
1	Antipsychotic Agents (Antipsychotics)IBA 03/2012
1	Serotonin (5 Hydroxytryptamine)IBA 10/2011
1	Methylphenidate (Ritalin)FDA LinkGeneric 08/2011